Health policy experts pushing for change in feds’ funding for research and development
Federal and provincial governments currently give pharmaceutical companies tax breaks and subsidies to encourage them to devote more of their budgets to developing new drugs.
Health policy experts are pushing for changes to the federal government's system of funding the research and development of new pharmaceuticals in the hopes of making drugs that are necessary to patients' health more affordable.
SPONSORED CONTENT
Get Tuesdays: Innovation & Industry Newsletter
The policies, decisions, and people working on investment and regulation in the industry and innovation realm.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
